Groupe Berkem Announces Its 2023 Financial Calendar

20 Dec 2022 18:00 CET

Regulatory News:

Groupe Berkem (the “Group”), a leading player in bio-based chemicals (ISIN code: FR00140069V2 – Ticker: ALKEM) (Paris:ALKEM), announces today its 2023 financial calendar.

* this information is subject to modification.

ABOUT GROUPE BERKEM

Founded in 1993 by Olivier Fahy, Chairman and Chief Executive Officer, Groupe Berkem is a leading force in the bio-based chemicals market. Its mission is to advance the environmental transition of companies producing the chemicals used in everyday lives (cosmetics, food and beverages, construction, public hygiene, etc.). By harnessing its expertise in both plant extraction and innovative formulations, Groupe Berkem has developed bio-based boosters—unique high-quality bio-based solutions augmenting the performance of synthetic molecules. Groupe Berkem achieved revenue of €46 million and an EBITDA margin close to 20% in 2021. The Group has almost 170 employees working at its head office (Blanquefort, Gironde) and three production facilities in Gardonne (Dordogne), La Teste-de-Buch (Gironde), and Chartres (Eure-et-Loir).

Groupe Berkem has been listed on Euronext Growth Paris since December 2021 (ISIN: FR00140069V2 – ALKEM).

www.groupeberkem.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20221220005558/en/

Groupe Berkem
Olivier Fahy, Chief Executive Officer
Anthony Labrugnas, Chief Financial Officer
Tel.: +33 (0)5 64 31 06 60
investisseurs@berkem.com

NewCap
Investor Relations
Mathilde Bohin / Nicolas Fossiez
Tel.: +33 (0)1 44 71 94 94
Berkem@newcap.eu

NewCap
Media Relations
Nicolas Merigeau/ Antoine Pacquier
Tel.: +33 (0)1 44 71 94 94
Berkem@newcap.eu